Mental Health News and Research

Latest Mental Health News and Research

Centre for Addiction and Mental Health to say goodbye to its landmark Administration Building

The Centre for Addiction and Mental Health (CAMH) will say goodbye to its landmark Administration Building at 1001 Queen St. West in a ceremony on October 29, 2009 at 4 p.m. Demolition of the building will begin in January 2010 to make way for the next major phase of CAMH's ambitious redevelopment project, which is transforming care for Ontarians living with addiction and mental health issues.

29 Oct 2009

PFNC presents Wake Forest psychiatrist the Eugene A. Hargrove, M.D., Award

Vaughn McCall, M.D., M.S., chair of Psychiatry and Behavioral Medicine at Wake Forest University Baptist Medical Center, has been presented the Eugene A. Hargrove, M.D., Award by the Psychiatric Foundation of North Carolina (PFNC).

29 Oct 2009

Positive top-line results from Phase IIb clinical trial of cariprazine announced

Forest Laboratories, Inc. and Gedeon Richter Plc today announced positive top-line results from a Phase IIb clinical trial of the novel, investigational antipsychotic agent cariprazine for the treatment of acute exacerbation of schizophrenia.

29 Oct 2009

CTE cases are misdiagnosed as Alzheimer's disease, says CSTE researchers

The Center for the Study of Traumatic Encephalopathy (CSTE) at Boston University School of Medicine (BUSM) announced today that a recently deceased member of the NFL Hall of Fame suffered from the degenerative brain disease Chronic Traumatic Encephalopathy (CTE) when he died, becoming the 10th former NFL player diagnosed with the disease.

29 Oct 2009

Treatment plan can benefit both doctor and patient

Jeff Gavin's diagnosis of leukemia last year threw him into a new world. Suddenly the father of five had to keep track of a bevy of new medicines and maintain a complicated series of appointments and hospital visits for chemotherapy.

29 Oct 2009

CNS Response to present results from depression efficacy study at U.S. Psychiatric and Mental Health Congress

CNS Response, Inc. announced that the company will present top-line results from its multi-site clinical trial next week at the U.S. Psychiatric and Mental Health Congress. "Referenced-EEG (rEEG®) Efficacy Compared to Star*D for Patients with Depression Treatment Failure: First Look at Final Results," will be presented by Charles DeBattista, M.D. on Monday, November 2nd, at 3:45 to 6:45 p.m. The conference is being held at the Mandalay Bay South Convention Center in Las Vegas, NV.

29 Oct 2009

Homelessness declines in Los Angeles; recession pave way for affordable housing

On any given night, an estimated 43,000 people are homeless in Los Angeles' Continuum of Care, according to the 2009 Greater Los Angeles Homeless Report (HC09), released today by the Los Angeles Homeless Services Authority (LAHSA). The number of homeless people in Los Angeles, while still the highest in the nation, represents an estimated 38% decrease from 2007.

29 Oct 2009

NIHR grant to support the development of the BRC's CRIS system

The specialist National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) for Mental Health at South London and Maudsley NHS Foundation Trust (SLaM) and Institute of Psychiatry (IoP) , King's College London (KCL) has been awarded nearly -1 million from the NIHR to support the development of the BRC's Case Register Interactive Search (CRIS) system.

29 Oct 2009

No scientific proof that patients with Alzheimer's disease benefit from drugs containing the agent memantine

There is no scientific proof that patients with moderate or severe Alzheimer's disease benefit from drugs containing the agent memantine. This is the conclusion in the final report that the Institute for Quality and Efficiency in Health Care (IQWiG) published in September 2009.

29 Oct 2009

Pregnant women with symptoms of depression have a stronger biological reaction to the seasonal flu vaccine

Pregnant women with significant symptoms of depression tend to have a stronger biological reaction to the seasonal flu vaccine than do women with lower depression levels, according to a new study.

29 Oct 2009

Study links low maternal folate levels with attention-deficit/hyperactivity problems in children

It has long been suggested that healthy folate (the natural form of folic acid) levels in expectant mothers goes hand in hand with healthy nervous system development in their children. A study published in an upcoming issue of the Journal of Child Psychology and Psychiatry finds that low maternal folate levels is linked to the development of attention-deficit/hyperactivity problems in children at age seven to nine years.

29 Oct 2009

Depressed people more likely to overstate the frequency of physical symptoms

New research shows people who feel depressed tend to recall having more physical symptoms than they actually experienced. The study indicates that depression -- not neuroticism -- is the cause of such over-reporting.

29 Oct 2009

CAMH Foundation receives $5 million gift for mental health research

An extraordinary gift of $5 million from Mr. G. Raymond Chang, Chancellor of Ryerson University and Chair of CI Financial, will go toward furthering research and education about the treatment of mental health and addictions, the Centre for Addiction and Mental Health (CAMH) Foundation announced today.

29 Oct 2009

Scientists test rapamycin's effectiveness at rescuing impaired nerve cells

Johns Hopkins scientists report having used a commercially available drug to successfully "rescue" animal brain cells that they had intentionally damaged by manipulating a newly discovered gene that links susceptibility genes for schizophrenia and autism.

28 Oct 2009

Two-year trial to test effectiveness of behavioral psychotherapy for young adolescents with autism

The USF Health Rothman Center for Neuropsychiatry in St. Petersburg, FL, is conducting a two-year federal trial testing the effectiveness of behavioral psychotherapy in treating anxiety among young adolescents with autism.

28 Oct 2009

New clinical uses for old hypertension drug leads to several patents

University of South Florida neuroscientist R. Douglas Shytle's discovery of successful new clinical uses for mecamylamine, a drug once used to treat hypertension, has led to several issued patents on mecamylamine and related compounds. Earlier this month, Shytle, associate professor and research scientist at the USF Center of Excellence for Aging and Brain Repair and the USF Silver Child Development Center, received the university's 2009 "Excellence in Innovation" award.

28 Oct 2009

TOPROL-XL and metoprolol succinate are available for patients in all regions across the country: AstraZeneca

Following published reports that two generic companies had recalled or suspended shipments of metoprolol succinate, a beta-blocker medication taken by over half a million Americans for the treatment of high blood pressure, TOPROL-XL and its authorized generic, metoprolol succinate extended-release tablets are available.

28 Oct 2009

IFPA urges WHO to act on new insights on psoriasis to help millions of psoriasis patients

October 29 is World Psoriasis Day. Conceived by patients for patients, World Psoriasis Day is a truly global event focusing on the burden of living with psoriasis. There are more than 125 million people with psoriasis/psoriatic arthritis in the world. Psoriasis is a severe chronic inflammatory disease that effects all ages, genders, races and ethnicities.

28 Oct 2009

NCKU transfers microalgal docosahexaenoic acid production technology to Vedan Biotechnology

NCKU President, Academician Michael Ming-Chiao Lai, signed Technology Transfer Agreement in this morning with Mr. Tou-Hsiung Yang, Chairman of Vedan International (Holding) Ltd, witnessed by Vedan Biotechnology President Shih-An (Raymond) Yang and the inventor, Prof. Huey-Lang Yang of the NCKU Institute of Biotechnology.

28 Oct 2009

Helix Hearing Care Centre and RA Centre host Healthy Aging Day

Helix Hearing Care Centre, The Senior Citizens Council of Ottawa, and the RA Centre hosted a Healthy Aging Day on Monday, where a capacity crowd of golden agers gathered to find out more about healthy hearing.

28 Oct 2009

Mental Health News and Research

Latest Mental Health News and Research

Centre for Addiction and Mental Health to say goodbye to its landmark Administration Building

PFNC presents Wake Forest psychiatrist the Eugene A. Hargrove, M.D., Award

Positive top-line results from Phase IIb clinical trial of cariprazine announced

CTE cases are misdiagnosed as Alzheimer's disease, says CSTE researchers

Treatment plan can benefit both doctor and patient

CNS Response to present results from depression efficacy study at U.S. Psychiatric and Mental Health Congress

Homelessness declines in Los Angeles; recession pave way for affordable housing

NIHR grant to support the development of the BRC's CRIS system

No scientific proof that patients with Alzheimer's disease benefit from drugs containing the agent memantine

Pregnant women with symptoms of depression have a stronger biological reaction to the seasonal flu vaccine

Study links low maternal folate levels with attention-deficit/hyperactivity problems in children

Depressed people more likely to overstate the frequency of physical symptoms

CAMH Foundation receives $5 million gift for mental health research

Scientists test rapamycin's effectiveness at rescuing impaired nerve cells

Two-year trial to test effectiveness of behavioral psychotherapy for young adolescents with autism

New clinical uses for old hypertension drug leads to several patents

TOPROL-XL and metoprolol succinate are available for patients in all regions across the country: AstraZeneca

IFPA urges WHO to act on new insights on psoriasis to help millions of psoriasis patients

NCKU transfers microalgal docosahexaenoic acid production technology to Vedan Biotechnology

Helix Hearing Care Centre and RA Centre host Healthy Aging Day

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Mental Health News and Research

Latest Mental Health News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in